OTC makers struggling to boost sales

Published: 2008-06-12 06:58:00

Updated: 2008-06-12 06:58:00

A red light is on for the nation's over-the-counter (OTC) makers as their flagship products, such as medical plasters and ginkgo biloba preparations, are not sold as expected earlier, although these items have been already excluded from the insurance list.

"We cannot paint a rosy picture on th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK